This high-impact forum for institutional investors and venture capital firms will feature updates from senior management of approximately 140 leading public and private companies across the Biotechnology, Specialty Pharmaceuticals, Medical Technology & Diagnostics and Healthcare Services sectors. The conference format features company presentations and one-on-one meetings, as well as panel and expert sessions.